Pulmonary Or Respiratory Drug Delivery Industry Insights 2025 – Market Forecast for Executives and Planners
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Pulmonary Or Respiratory Drug Delivery Market Size Changed, over the years?
There has been robust growth in the market size for pulmonary or respiratory drug delivery in the recent years. It is projected to expand from a value of $69.83 billion in 2024 to a bigger value of $76.38 billion in 2025, with a compound annual growth rate (CAGR) hitting 9.4%. Factors that fueled the growth during the historic period include a surge in asthma cases, increased uptake of cutting-edge inhalation devices, global hike in healthcare spending, heightened knowledge about respiratory diseases, and a mounting number of allergy-related conditions.
How Much Will the Pulmonary Or Respiratory Drug Delivery Market Be Worth in 2029?
The market for pulmonary or respiratory drug delivery is poised to experience robust growth in the coming years with the market size predicted to rise to $107.85 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.0%. This significant growth during the projected period is due to factors such as the surge in demand for personalized healthcare, the increasing cases of chronic respiratory diseases, heightened focus on telemedicine, escalated investment in healthcare infrastructure, and the expansion of e-commerce in the pharmaceutical sector. Additionally, key trends to watch in this period include evolving particle engineering technology, the creation of more advanced nebulizers, the development of liposomal formulations, improvements in computational fluid dynamics, and the emergence of smart inhalers.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20939&type=smp
Which is the Largest Company in the Pulmonary Or Respiratory Drug Delivery Market?
Major companies operating in the pulmonary or respiratory drug delivery market are Merck & Co. Inc., Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, 3M Company, Koninklijke Philips N.V., GlaxoSmithKline, Omron Corporation, Teva Pharmaceutical Industries Ltd., Aptar Pharma, Sumitomo Pharma America Inc., Chiesi Farmaceutici S.p.A., Cipla Inc., Boehringer Ingelheim GmbH, Kindeva Drug Delivery Limited, Nemera Group, Hovione, H And T Presspart Group, Vectura Group plc
What Are the Main Market Drivers in the Pulmonary Or Respiratory Drug Delivery Industry?
The rise in pneumonia cases is predicted to contribute to the expansion of the pulmonary or respiratory drug delivery market. Pneumonia, a lung infection causing inflammation and potentially fluid or pus in the air sacs, results in symptoms like coughing, fever, and difficulty in breathing. Factors such as aging populations, weakened immune systems, respiratory infections, air pollution, smoking, and the increasing prevalence of antibiotic-resistant bacteria significantly contribute to the escalation of pneumonia cases. The application of pulmonary or respiratory drugs provides a direct target to the lungs with medications like antibiotics, bronchodilators, or anti-inflammatory agents. This facilitates faster and more efficient treatments, mitigating symptoms, reducing inflammation, eradicating infections, and enhancing respiratory function, thereby expediting recovery and averting complications. For example, in November 2023, the Centre for Tropical Medicine and Global Health, a prominent leader in healthcare research based in the UK, reported a substantial rise in pneumonia cases in Kenya, registering 793,864 in 2022/2023. Hence, the growing incidence of pneumonia fuels the progression of the pulmonary or respiratory drug delivery market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=20939&type=smp
How Is the Pulmonary Or Respiratory Drug Delivery Market Segments Structured?
The pulmonary or respiratory drug delivery market covered in this report is segmented –
1) By Product: Formulation Type, Device Type
2) By Canister Type: Plain Canister, Coated Canister
3) By Application: Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Other Applications
4) By End-User: Hospitals, Clinics, Home Care Settings
Subsegments:
1) By Formulation Type: Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), Nebulizers, Liquid Aerosols, Nasal Sprays
2) By Device Type: Inhalers (Manual and Digital), Nebulizers (Compressor, Ultrasonic, Mesh), Breath-Activated Devices, Spacer Devices, Nasal Drug Delivery Devices
What Strategic Trends Are Transforming the Pulmonary Or Respiratory Drug Delivery Market?
In the pulmonary or respiratory drug delivery market, key players are emphasizing the importance of technological advancements like sophisticated drug delivery systems to increase treatment effectiveness and patient adherence. These sophisticated drug delivery systems are cutting-edge technologies that amplify the targeted delivery and controlled release of medicinal agents, heightening drug effectiveness and patient results. For example, Viatris Inc., a US healthcare company producing generic and branded drugs, and Kindeva Drug Delivery L.P., a US corporation offering drug delivery, launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol in July 2023. It was approved by the FDA, a US government agency, making it the first generic version of AstraZeneca’s Symbicort and a metered-dose inhaler combining budesonide and formoterol for the treatment of asthma and chronic obstructive pulmonary disease. It comes in two strengths, 80 micrograms, and 160 micrograms, with 4.5 micrograms of formoterol.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Pulmonary Or Respiratory Drug Delivery Market?
North America was the largest region in the pulmonary or respiratory drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pulmonary or respiratory drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20939
This Report Delivers Insight On:
1. How big is the pulmonary or respiratory drug delivery market, and how is it changing globally?
2. Who are the major companies in the pulmonary or respiratory drug delivery market, and how are they performing?
3. What are the key opportunities and risks in the pulmonary or respiratory drug delivery market right now?
4. Which products or customer segments are growing the most in the pulmonary or respiratory drug delivery market?
5. What factors are helping or slowing down the growth of the pulmonary or respiratory drug delivery market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
